文献速递眼底病与葡萄膜炎

光感受器层变薄是年龄相关性黄斑变性的早期生物标志物:来自英国生物银行OCT数据的流行病学与遗传学证据

Photoreceptor Layer Thinning Is an Early Biomarker for Age-Related Macular Degeneration: Epidemiologic and Genetic Evidence from UK Biobank OCT Data.
PubMed 文献 · Ophthalmology · 2022-02-08

研究发现光感受器节段(PS)变薄贯穿一生,而视网膜色素上皮(RPE)和布鲁赫膜(BM)复合体增厚始于57岁后;PS变薄对未来AMD风险的预测最强,AMD风险变异与PS变薄相关。

要点

  • PS变薄贯穿一生,RPE-BM复合体增厚始于57岁后,PS变薄早于RPE-BM增厚数十年。
  • PS每变薄1个标准差, incident AMD的HR为1.35(95%CI 1.23-1.47)。
  • AMD多基因风险评分与PS变薄相关(β=-0.21 SD每两倍遗传风险,95%CI -0.23至-0.19)。

核心结论

  • 流行病学上,PS变薄先于RPE-BM复合体增厚数十年,且是对未来AMD风险预测最强的视网膜层。
  • 遗传学上,AMD风险变异与PS厚度降低相关。
  • 总体而言,这些发现支持PS变薄作为未来AMD发生的早期生物标志物。

研究设计与样本

  • 使用Topcon高级边界分割算法进行视网膜层分割。
  • 采用 logistic 回归分析9种视网膜层厚度与 prevalent AMD(入组时存在)的关联,采用 Cox 比例风险模型分析其与 incident AMD(入组后诊断)的关联。
  • 分析AMD相关遗传等位基因(单个及多基因风险评分)与视网膜层厚度的关联,所有分析均校正年龄、年龄平方、性别、吸烟状态和祖先主成分。

主要发现

  • PS变薄在分析个体的一生中均可观察到,而RPE-BM复合体增厚在57岁后开始。
  • PS每变薄1个标准差与 incident AMD 相关(HR 1.35;95%CI 1.23-1.47;P=3.7×10⁻¹¹);RPE-BM复合体每增厚1个标准差与 incident AMD 相关(HR 1.14;95%CI 1.06-1.22;P=0.00024)。
  • AMD多基因风险评分与PS变薄相关(β=-0.21 SD每两倍遗传风险增加;95%CI -0.23至-0.19;P=2.8×10⁻⁷⁴)。
  • AMD多基因风险评分与RPE-BM复合体的关联呈U形:当AMD多基因风险评分低于第92百分位时变薄,高于第92百分位时增厚。

关键数值与推荐

  • 对遗传相关性支持最强的位点:增加AMD风险的变异CFH:rs570618-T、CFH:rs10922109-C和ARMS2/HTRA1:rs3750846-C与PS变薄相关。
  • SYN3/TIMP3:rs5754227-T与RPE-BM复合体增厚相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Despite widespread use of OCT, an early-stage imaging biomarker for age-related macular degeneration (AMD) has not been identified. Pathophysiologically, the timing of drusen accumulation in relationship to photoreceptor degeneration in AMD remains unclear, as are the inherited genetic variants contributing to these processes. Herein, we jointly analyzed OCT, electronic health record data, and genomic data to characterize the time sequence of changes in retinal layer thicknesses in AMD, as well as epidemiologic and genetic associations between retinal layer thicknesses and AMD. DESIGN: Cohort study. PARTICIPANTS: Forty-four thousand eight hundred twenty-three individuals from the UK Biobank (enrollment age range, 40-70 years; 54% women; median follow-up, 10 years). METHODS: The Topcon Advanced Boundary Segmentation algorithm was used for retinal layer segmentation. We associated 9 retinal layer thicknesses with prevalent AMD (present at enrollment) in a logistic regression model and with incident AMD (diagnosed after enrollment) in a Cox proportional hazards model. Next, we associated AMD-associated genetic alleles, individually and as a polygenic risk score (PRS), with retinal layer thicknesses. All analyses were adjusted for age, age-squared (age2), sex, smoking status, and principal components of ancestry. MAIN OUTCOME MEASURES: Prevalent and incident AMD. RESULTS: Photoreceptor segment (PS) thinning was observed throughout the lifespan of individuals analyzed, whereas retinal pigment epithelium (RPE) and Bruch's membrane (BM) complex thickening started after 57 years of age. Each standard deviation (SD) of PS thinning and RPE-BM complex thickening was associated with incident AMD (PS: hazard ratio [HR], 1.35; 95% confidence interval [CI], 1.23-1.47; P = 3.7 × 10-11; RPE-BM complex: HR, 1.14; 95% CI, 1.06-1.22; P = 0.00024). The AMD PRS was associated with PS thinning (β, -0.21 SD per twofold genetically increased risk of AMD; 95% CI, -0.23 to -0.19; P = 2.8 × 10-74), and its association with RPE-BM complex was U-shaped (thinning with AMD PRS less than the 92nd percentile and thickening with AMD PRS more than the 92nd percentile). The loci with strongest support for genetic correlation were AMD risk-raising variants Complement Factor H (CFH):rs570618-T, CFH:rs10922109-C, and Age-Related Maculopathy Susceptibility 2 (ARMS2)/High-Temperature Requirement Serine Protease 1 (HTRA1):rs3750846-C on PS thinning and SYN3/Tissue Inhibitor of Metalloprotease 3 (TIMP3):rs5754227-T on RPE-BM complex thickening. CONCLUSIONS: Epidemiologically, PS thinning precedes RPE-BM complex thickening by decades and is the retinal layer most strongly predictive of future AMD risk. Genetically, AMD risk variants are associated with decreased PS thickness. Overall, these findings support PS thinning as an early-stage biomarker for future AMD development.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Zekavat SM, Sekimitsu S, Ye Y, et al. Photoreceptor Layer Thinning Is an Early Biomarker for Age-Related Macular Degeneration: Epidemiologic and Genetic Evidence from UK Biobank OCT Data. Ophthalmology. 2022. PMID: 35149155. doi:10.1016/j.ophtha.2022.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。